Ignite Creation Date:
2024-05-06 @ 12:06 PM
Last Modification Date:
2024-10-26 @ 12:54 PM
Study NCT ID:
NCT03671564
Status:
COMPLETED
Last Update Posted:
2023-11-07
First Post:
2018-09-04
Brief Title:
Study of Milademetan in Japanese Patients With Relapsed or Refractory Acute Myeloid Leukemia AML
Sponsor:
Organization:
Daiichi Sankyo